EAM Investors, LLC - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 128 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2015$1,331,000
+38.4%
169,938
+8.5%
0.15%
-19.8%
Q3 2013$962,000
-3.6%
156,674
-8.2%
0.19%
-11.5%
Q2 2013$998,000170,5770.22%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 1,250,000$8,125,0005.71%
Rock Springs Capital Management LP 830,000$5,395,0001.24%
First Light Asset Management, LLC 195,359$1,270,0000.90%
Palo Alto Investors LP 3,338,048$21,698,0000.90%
Rhenman & Partners Asset Management AB 329,199$2,140,0000.64%
NEA Management Company, LLC 1,935,300$12,579,0000.62%
PFM Health Sciences, LP 5,129,129$33,339,0000.60%
Sivik Global Healthcare LLC 124,145$807,0000.50%
QVT Financial LP 1,322,729$8,598,0000.49%
ESSEX INVESTMENT MANAGEMENT CO LLC 433,657$2,819,0000.41%
View complete list of OREXIGEN THERAPEUTICS INC shareholders